Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Pietro Pioltelli"'
Autor:
Mohamed A. Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, Urpu Salmenniemi, Stephan Mielke, Patrice Chevallier, Marie Thérèse Rubio, Marie Balsat, Pietro Pioltelli, Anne-Lise Menard, Gerard Socié, Anne Huynh, Nicolaas Schaap, Arancha Bermúdez Rodríguez, Jan J. Cornelissen, Ibrahim Yakoub-Agha, Mahmoud Aljurf, Sebastian Giebel, Eolia Brissot, Zina Peric, Arnon Nagler, Mohamad Mohty
Publikováno v:
HemaSphere, Vol 6, Iss 11, p e788 (2022)
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adult acute lymphoblastic leukemia (ALL) have improved over time. Studies have shown that total body irradiation (TBI) is the preferable type of myeloablative conditioning (MAC)
Externí odkaz:
https://doaj.org/article/377096218ba64bf099e65d8a8619db34
Autor:
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Pietro Pioltelli, Mutlu Arat, Ibrahim Yakoub-Agha, Alexander Kulagin, Anna Maria Raiola, Hakan Ozdogu, Antonio Risitano, Zubeyde Nur Ozkurt, Jaime Sanz, Eolia Brissot, Peric Zina, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
Publikováno v:
HemaSphere, Vol 6, Iss 11, p e790 (2022)
The results of haploidentical stem cell transplantation (haploHCT) for patients with acute lymphoblastic leukemia (ALL) transplanted in active disease remain largely unknown. We retrospectively analyzed adult patients with R/R ALL who underwent haplo
Externí odkaz:
https://doaj.org/article/23bb4f348c6946d3aa80de582a06b9e8
Autor:
Arnon Nagler, Abraham S. Kanate, Myriam Labopin, Fabio Ciceri, Emanuele Angelucci, Yener Koc, Zafer Gülbas, William Arcese, Johanna Tischer, Pietro Pioltelli, Hakan Ozdogu, Boris Afanasyev, Depei Wu, Mutlu Arat, Zinaida Peric, Sebastian Giebel, Bipin Savani, Mohamad Mohty
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
Graft-versus-host disease (GVHD) prophylaxis for unmanipulated haploidentical hematopoietic cell transplantation (haplo-HCT) include post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG). Utilizing EBMT registry, we compared ATG v
Externí odkaz:
https://doaj.org/article/7654c33112014681aa7491b9c007b1fe
Autor:
Nico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, Linda Koster, Hareth Nahi, Anne-Marie Stoppa, Tamás Masszi, Denis Caillot, Stig Lenhoff, Miklos Udvardy, Charles Crawley, William Arcese, Clara Mariette, Ann Hunter, Xavier Leleu, Martin Schipperus, Michel Delforge, Pietro Pioltelli, John A. Snowden, Maija Itälä-Remes, Maurizio Musso, Anja van Biezen, Laurent Garderet, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 103, Iss 5 (2018)
We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first-line autologous stem cell transplantation. We identified 3744 adult myeloma patients who received up-front single (n=3391) o
Externí odkaz:
https://doaj.org/article/06bc03d29827406b9491d6f70c0b97bf
Autor:
Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015041-e2015041 (2015)
Background and Objectives: Acute lymphoblastic leukaemia (ALL) carrying t(9;22) or t(4;11) genetic abnormalities represents a very high risk subtype of disease (VHR-ALL). Hematopoietic stem cell transplantation (HSCT) still remains the only curative
Externí odkaz:
https://doaj.org/article/af5ecefb6c764378a94c334348a27b1b
Autor:
Valli De Re, Laura Caggiari, Mariangela De Zorzi, Ombretta Repetto, Anna Linda Zignego, Francesco Izzo, Maria Lina Tornesello, Franco Maria Buonaguro, Alessandra Mangia, Domenico Sansonno, Vito Racanelli, Salvatore De Vita, Pietro Pioltelli, Emanuela Vaccher, Massimiliano Berretta, Cesare Mazzaro, Massimo Libra, Andrea Gini, Antonella Zucchetto, Renato Cannizzaro, Paolo De Paoli
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117420 (2015)
BACKGROUND:The variability in the association of host innate immune response to Hepatitis C virus (HCV) infection requires ruling out the possible role of host KIR and HLA genotypes in HCV-related disorders: therefore, we therefore explored the relat
Externí odkaz:
https://doaj.org/article/c07f0f01734446538be26e9947322686
Autor:
Valli De Re, Laura Caggiari, Mariangela De Zorzi, Ombretta Repetto, Anna Linda Zignego, Francesco Izzo, Maria Lina Tornesello, Franco Maria Buonaguro, Alessandra Mangia, Domenico Sansonno, Vito Racanelli, Salvatore De Vita, Pietro Pioltelli, Emanuela Vaccher, Massimiliano Beretta, Cesare Mazzaro, Massimo Libra, Andrea Gini, Antonella Zucchetto, Renato Cannizzaro, Paolo De Paoli
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0128849 (2015)
Externí odkaz:
https://doaj.org/article/e60a36cabd8f4ce5ab18f5f631fe0249
Autor:
Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014042-e2014042 (2014)
Deferasirox (DSX) is the principal option currently available for iron-chelation-therapy (ICT), principally in the management of myelodysplastic syndromes (MDS), while in primary myelofibrosis (PMF) the expertise is limited. We analyzed our experienc
Externí odkaz:
https://doaj.org/article/2dd99b1c30184f009aa9950a59c8cb92
Autor:
Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 2, Pp e2010010-e2010010 (2010)
Background Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for myelofibrosis (MI), though limited by a high rate of transplant-related mortality (TRM). . In the present study we evaluate the outcome of MI patients under
Externí odkaz:
https://doaj.org/article/aa493e1019264092bd50d0e60037a37c
Autor:
Miriam Isola, Alessandra Sperotto, Andrea Bacigalupo, Francesca Patriarca, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 2, Pp e2010010-e2010010 (2010)
BackgroundAllogeneic stem cell transplantation (SCT) is a potentially curative treatment for myelofibrosis (MI), though limited by a high rate of transplant-related mortality (TRM). . In the present study we evaluate the outcome of MI patients underg
Externí odkaz:
https://doaj.org/article/8fc56ffc41c84e439de6e835117630c5